Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 24,603 | 25,987 | 22,729 | 24,248 | 20,134 |
| Operating Income | -24,603 | -25,987 | -22,729 | -24,248 | -20,134 |
| Other Income | 4,653 | 3,249 | 3,359 | 3,479 | 3,413 |
| Pre-tax Income | -19,950 | -22,738 | -19,370 | -20,769 | -16,721 |
| Net Income Continuous | -19,950 | -22,738 | -19,370 | -20,769 | -16,721 |
| Net Income | $-19,950 | $-22,738 | $-19,370 | $-20,769 | $-16,721 |
| EPS Basic Total Ops | -0.41 | -0.54 | -0.29 | -0.51 | -0.41 |
| EPS Basic Continuous Ops | -0.42 | -0.54 | -0.30 | -0.51 | -0.41 |
| EPS Diluted Total Ops | -0.41 | -0.54 | -0.29 | -0.51 | -0.41 |
| EPS Diluted Continuous Ops | -0.42 | -0.54 | -0.30 | -0.51 | -0.41 |
| EPS Diluted Before Non-Recurring Items | -0.41 | -0.54 | -0.47 | N/A | N/A |
| EBITDA(a) | $-25,128 | $-26,569 | $-24,439 | $-26,154 | $-20,891 |